Absci to Participate in Upcoming Investor Conferences | $ABSI
VANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences:
$ABSI
NASDAQ
Absci Corporation
Market Snapshot
Delayed market data
Market data displayed by TradingView.
Market data may be delayed.
Chart
Absci Corporation
Range
1 month
Chart loads when visible
Latest
Coverage
You are up to date.